The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model Pilot Program with a start date of Jan.
Lawmakers across the country are working through bills written to shield a growing source of revenue for hospital systems and ...
The University of Miami Health Systems allegedly deleted a recent social media post celebrating an international expansion, ...
On October 31, 2025, the Centers for Medicare & Medicaid Services (CMS) issued the physician fee schedule (PFS) final rule for calendar year (CY) ...
Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...
No monitoring and measurement effort will be more important to the long-term health of communities than understanding and ...
The Centers for Medicare & Medicaid Services Oct. 31 released its calendar year 2026 final rule for the physician fee schedule.
This week, the government shutdown entered its fifth week and, on Nov. 4, 2025, became the longest in history, beating a 34-day-plus record set ...
CMS finalizes 2026 physician fee schedule, introducing two conversion factors and updates to practice expense methodology for Medicare payments.
PHILADELPHIA, November 03, 2025--(BUSINESS WIRE)--IntegriChain, the leading provider of pharma revenue optimization ...
The Eastern Rio Blanco County Health Service District’s Pioneers Medical Center (PMC) board held its regular meeting last ...
Court rejects AbbVie 340B restrictions, upholding Colorado law protecting contract pharmacies under the 340B Drug Pricing Program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback